SK Hynix Earnings Soar 256.8% YoY: Upside Case Ahead SK Hynix is rated Buy as AI-driven memory demand fuels explosive revenue and profit growth, with very high margins, strong analyst consensus, and upside despite cycle and margin-compression risks. 2026년 10월 06일 English
Samsung Biologics Q2 Earnings Climb – More Upside Than Valuation Signals Samsung Biologics has Buy consensus and strong results: revenue up 30%, operating profit up 23%, net income up 33%, with margins at 54% gross and 44% operating, while the stock trades below the average target of about 1.97M won. 2026년 10월 01일 English
Hyundai Mobis Stock Rallies as Profit Growth Improves – Upside Risk/Reward Hyundai Mobis has Buy consensus as valuation lags earnings: revenue up 2.4% YoY, operating profit up 12.1%, net income up 13.5%, with upside to average targets, despite supply chain execution risks. 2026년 09월 29일 English
SK Holdings Revenue and Profit Surge: Valuation Upside SK Holdings earns Buy consensus as recent results show strong revenue and operating profit, high ROE, and cheap valuation versus earnings power, despite semiconductor cycle fears and upside targets around 52%. 2026년 09월 03일 English
Hanwha Ocean Wins LNG Ship Order – Earnings Boost Insight Hanwha Ocean sees strong LNG eco-ship order momentum, with profit surging despite flat revenue, but faces arbitration risk from Arctic LNG 2; analysts rate it a Buy. 2026년 09월 03일 English
Samsung Earnings Soar on AI Demand: Profit Insight Samsung Electro-Mechanics earns accelerating fast, with net profit up 86.3% YoY, boosted by AI-linked MLCC and advanced packaging demand; consensus is Buy. 2026년 08월 20일 English
POSCO Holdings Trades Low PER as Earnings Accelerate: Upside POSCO Holdings is rated Buy as profits accelerate strongly YoY with a low forward PER, while lithium and LNG exposure may improve margins; key risk is margin durability and low ROE. 2026년 08월 04일 English
Hanwha Ocean Earnings Rebound Sparks Bullish Upside – Key Takeaways Hanwha Ocean earns rebound and margin expansion drive strong profit growth, while labor and delivery risks still weigh; analysts rate it Buy with upside versus current price. 2026년 07월 29일 English
현대중공업 실적 분석과 주가 전망 투자 전략 현대중공업 매수 의견. 매출과 영업이익 순이익이 급증하며 PER 13.5배로 밸류 매력은 있음. 다만 안전 셧다운과 사고 리스크로 단기 변동성 주의. 2026년 07월 28일 Korean
Hanmi Pharmaceutical Stock Resilient Despite Profit Dip: Key Insight Hanmi Pharmaceutical stock is discounted by governance and K-bio sentiment, but earnings remain resilient with net income up 6.8% YoY; analysts see Buy with 51% upside to the 624,615 won average target. 2026년 07월 09일 English
